Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

ICICI Lombard General Insurance Company - Strong franchise should benefit from cycle recovery - ICICI Securities

Posted On: 2020-10-25 23:47:13


We upgrade ICICI Lombard (ICICIGI) from Add to BUY on expected ~30% earnings CAGR in FY20-22E as multiple elements point towards a positive business cycle for general insurance in the near term. ICICIGI will be a key beneficiary. The combination of low growth in motor premiums, higher Covid-19 claims, no hike in motor TP rates point to a business trough in H1FY21. Going ahead, there should be pickup in motor insurance (economic recovery plus a lower base), better earnings from health segment (growth in health premiums will be structural compared to immediate claims) and inflationary hike in motor TP rates. For reference, Chinese health/overall non-life insurance premiums for insurer Ping An grew 39%/14% YoY from April - Sept'20 (i.e post the Covid-19 peak during March) and China Life's (health segment) grew 15.8% YoY in H1CY20. Our DCF-based target price of Rs1,505 implies 38x FY22E EPS of ~Rs40.

- Earnings get a boost from positive experience in H1FY21; expect Rs15bn PAT in FY21 (+27% YoY). Positive drivers in H1FY21 were lower loss ratios in motor (more for TP than OD), manageable loss ratios in health and market share gain in motor (which had lower loss ratios) partially offset by higher expense ratio. Based on 5% growth in NEP (7% NEP growth in 2HFY21 compared to 4% in 1HFY21), 72% loss ratio (75% loss ratio in 2HFY21 compared to 68% in 1HFY21), 28% opex ratio (commission plus expense) (25% opex ratio in 2HFY21 {average Opex ratio between FY17-20 was 24%} as compared to 31% in 1HFY21), Rs18bn investment income (Rs7.4bn in 2HFY21 compared to Rs10.6bn in 1HFY21), we estimate Rs15bn PAT in FY21.

- H1FY21 performance reiterates business strength, earnings worth Rs20bn achievable by FY23. This should be achievable within the constructs of 15-20% growth and 98-100% combined ratio aided by the fact that CAGR parity in growth is likely to be restored post the dip in FY21. We believe the parameter of growth and combined ratio should have a favorable trajectory in a positive business cycle.

- Strong execution and robust balance sheet will further benefit ICICIGI. ICICIGI has managed strong organic expansion with agents increasing from 35,729 in FY19 to 52,785 in Q2FY21 and virtual offices increasing from 135 in FY18 to 840 in Q2FY21. ICICIGI has also embarked on inorganic growth with the acquisition of Bharti Axa which had 1.7% GDPI market share in FY20, Additionally, it also acquired AutoNinja (CRM software for auto dealers) in Nov'19 which has helped renewal rate in motor insurance. ICICIGI remains committed to prudent reserving which has led to management exuding high confidence in maintaining aggregate loss ratios in FY21 to similar levels of FY20 (we expect lower). ICICIGI has maintained strong execution (39% growth in health indemnity over last, 37% growth in SME in H1FY21) along with underwriting discipline (abstained from crop since Mar'19 which should also lead to negligible impact from Kharif claims in Q3, maintained low and nimble exposure to CV mix). This superior execution track record will be further aided by strong balance sheet with solvency of 2.74x as of H1FY21 and an AUM including fair value change account of Rs281bn (equity exposure remains ~10.2%).

Shares of ICICI Lombard General Insurance Company Ltd was last trading in BSE at Rs.1254.95 as compared to the previous close of Rs. 1256.45. The total number of shares traded during the day was 7380 in over 983 trades.

The stock hit an intraday high of Rs. 1265 and intraday low of 1241.3. The net turnover during the day was Rs. 9240850.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com



Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Initiating Coverage on Godrej Properties - The housing factory - HDFC Securities

Burger King IPO - Angel Broking

Rollover Analysis - Record foreign inflows pushes Nifty to 13k - YES Securities

Ceramic tiles industry - Market share gains sustain for top branded players - ICICI Securities

Gas sector - CGD: Competition to hit margins, volumes and lead to derating - ICICI Securities

Cement - Prices resilient in Q3; consensus upgrades to continue - ICICI Securities

Specialty chemicals - Price trend in Sep-20 - ICICI Securities

Timken India - Q2FY21 Company Update - ICICI Direct

Upgrade in target price of IDFC First Bank - Angel Broking

Laurus Labs stake acquisition in Richore Lifesciences - Angel Broking

Shares of Lakshmi Vilas Bank (LVB) suspended from trading - Angel Broking

Initiating Coverage on Sundram Fasteners - Fastening growth - HDFC Securities

Astral Poly Technik - Scalability to further improve with storage tanks foray - ICICI Securities

Vardhman Special Steel - Q2FY21 Company Update - ICICI Direct

Initiating Coverage - Advanced Enzyme Technologies - ICICI Direct

L&T - Secures Large Contract - Nov 25, 2020 - Angel Broking

Alembic Pharmaceuticals - Tentative Approval for JV - Angel Broking

Drug launch by Lupin - Tacrolimus Capsules - Angel Broking

Gujarat Gas - Nov 25, 2020 - Angel Broking

Metropolis Healthcare - Nov 25, 2020 - Angel Broking

NTPC - Showcase of strength & competitiveness - ICICI Securities

Telecom - Market Share TRACKER - Bharti is narrowing the gap on incremental market share vs RJio - ICICI Securities

Cochin Shipyard - Q2FY21 Result Update - ICICI Direct

Engineers India - Q2FY21 Result Update - ICICI Direct

Rupee - Nov 24, 2020 - Reliance Securities

FMCG Sector Update - Recovery unlocked; lower growth divergence - HDFC Securities

Engineers India - Consultancy segment outperformance - ICICI Securities

Engineers India - Q2 FY21 Result Update - YES SECURITIES

Motherson Sumi Systems - Company Update - Virtual Investor Conference - ICICI Direct

Mutual Fund Review - November, 2020 - ICICI Direct

Sadbhav Engineering - Q2FY21 Company Update - ICICI Direct

IRB Infrastructure - Q2FY21 Company Update - ICICI Direct

Vodafone Idea fund raising - Angel Broking

Rupee - Nov 23, 2020 - Reliance Securities

Crude Oil - Nov 23, 2020 - Reliance Securities

Q2FY21 Bank Result Quick Review - Angel Broking

Banks & NBFC's Sector Update Report - Yet another watershed moment? - HDFC Securities

Galaxy Surfactants - EBITDA/kg has an upside risk - ICICI Securities

Diagnostics - COVID-19 tests continue to trend higher - ICICI Securities

Banking & Financial Services - Sector Update - Nov 22, 2020 - ICICI Direct

Dalmia Bharat Sugar - Q2FY21 Company Update - ICICI Direct

Balkrishna Industries - Industry export growth momentum continues - ICICI Securities

Covid Recovery Pulse - Festive positivity continues in auto retails, E-way bill generation improves... - ICICI Direct

Quant Pick - Exide Industries - ICICI Direct

Shankara Building Products - Q2FY21 Company Update - ICICI Direct

Triveni Engineering - Q2FY21 Company Update - ICICI Direct

Initiating Coverage on Sudarshan Chemical - Leaping into the league of giants - HDFC Securities

Earnings Wrap Q2FY21: Earnings outperform, post Covid recovery picks up steam - ICICI Direct

Vodafone Idea Positive development beneficial for IDFC first bank - Angel Broking

Lakshmi Vilas Bank - Angel Broking



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019